TY - JOUR
T1 - Return of genetic research results in 21,532 individuals with autism
AU - The SPARK Consortium
AU - Wright, Jessica R.
AU - Astrovskaya, Irina
AU - Barns, Sarah D.
AU - Goler, Alexandra
AU - Zhou, Xueya
AU - Shu, Chang
AU - Snyder, Lee Anne Green
AU - Han, Bing
AU - Aarrestad, Alexandria
AU - Abbeduto, Leonard
AU - Aberbach, Gabriella
AU - Aberle, Shelley
AU - Adegbite, Adediwura
AU - Adeniji, Debbie
AU - Aguilar, Maria
AU - Ahlers, Kaitlyn
AU - Albright, Charles
AU - Alessandri, Michael
AU - Algaze, Zach
AU - Alkazi, Jasem
AU - Amador, Raquel
AU - Amaral, David
AU - Amon, Logan
AU - Amundsen, Leonor
AU - Andrus, Alicia
AU - Anglo, Claudine
AU - Annett, Robert
AU - Arar, Adam
AU - Arnold, Jonathan
AU - Arriaga, Ivette
AU - Arzate, Eduardo
AU - Ashley, Raven
AU - Aslamy, Leilemah
AU - Baalman, Kelli
AU - Baer, Melissa
AU - Bahi, Ethan
AU - Bailey, Joshua
AU - Baldlock, Zachary
AU - Banks, Grabrielle
AU - Baraghoshi, Gabriele
AU - Bardett, Nicole
AU - Barrett, Mallory
AU - Bartholomew, Yan
AU - Bates, Heidi
AU - Beard, Katie
AU - Becerra, Juana
AU - Beckwith, Malia
AU - Beechan, Paige
AU - Beeson, Landon
AU - Soorya, Latha
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/10
Y1 - 2024/10
N2 - Purpose: The aim of this study is to identify likely pathogenic (LP) and pathogenic (P) genetic results for autism that can be returned to participants in SPARK (SPARKforAutism.org): a large recontactable cohort of people with autism in the United States. We also describe the process to return these clinically confirmed genetic findings. Methods: We present results from microarray genotyping and exome sequencing of 21,532 individuals with autism and 17,785 of their parents. We returned LP and P (American College of Medical Genetics criteria) copy-number variants, chromosomal aneuploidies, and variants in genes with strong evidence of association with autism and intellectual disability. Results: We identified 1903 returnable LP/P variants in 1861 individuals with autism (8.6%). 89.5% of these variants were not known to participants. The diagnostic genetic result was returned to 589 participants (53% of those contacted). Features associated with a higher probability of having a returnable result include cognitive and medically complex features, being female, being White (versus non-White) and being diagnosed more than 20 years ago. We also find results among autistics across the spectrum, as well as in transmitting parents with neuropsychiatric features but no autism diagnosis. Conclusion: SPARK offers an opportunity to assess returnable results among autistic people who have not been ascertained clinically. SPARK also provides practical experience returning genetic results for a behavioral condition at a large scale.
AB - Purpose: The aim of this study is to identify likely pathogenic (LP) and pathogenic (P) genetic results for autism that can be returned to participants in SPARK (SPARKforAutism.org): a large recontactable cohort of people with autism in the United States. We also describe the process to return these clinically confirmed genetic findings. Methods: We present results from microarray genotyping and exome sequencing of 21,532 individuals with autism and 17,785 of their parents. We returned LP and P (American College of Medical Genetics criteria) copy-number variants, chromosomal aneuploidies, and variants in genes with strong evidence of association with autism and intellectual disability. Results: We identified 1903 returnable LP/P variants in 1861 individuals with autism (8.6%). 89.5% of these variants were not known to participants. The diagnostic genetic result was returned to 589 participants (53% of those contacted). Features associated with a higher probability of having a returnable result include cognitive and medically complex features, being female, being White (versus non-White) and being diagnosed more than 20 years ago. We also find results among autistics across the spectrum, as well as in transmitting parents with neuropsychiatric features but no autism diagnosis. Conclusion: SPARK offers an opportunity to assess returnable results among autistic people who have not been ascertained clinically. SPARK also provides practical experience returning genetic results for a behavioral condition at a large scale.
KW - Autism
KW - Clinical genetics
KW - Exome sequencing
KW - Neurodevelopmental conditions
KW - Return of results
UR - https://www.scopus.com/pages/publications/85202820885
U2 - 10.1016/j.gim.2024.101202
DO - 10.1016/j.gim.2024.101202
M3 - Article
C2 - 38958063
AN - SCOPUS:85202820885
SN - 1098-3600
VL - 26
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 10
M1 - 101202
ER -